LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,416,157
تعداد دریافت فایل اصل مقاله11,291,885
Masoumi, Seyed Jalil, Haghani, Masoud, Mokkaram, Pooneh, Firoozi, Donya, Mortazavi, Seyed Ali Reza, Moradi Ardekani, Fariba, Torabi Ardakani, Atefeh, Mortazavi, Seyed Mohammad Javad. (1402). Family History of Alzheimer’s Disease Increases the Risk of COVID-19 Positivity: A SUMS Employees Cohort-based Study. سامانه مدیریت نشریات علمی, 13(4), 363-366. doi: 10.31661/jbpe.v0i0.2104-1318
Seyed Jalil Masoumi; Masoud Haghani; Pooneh Mokkaram; Donya Firoozi; Seyed Ali Reza Mortazavi; Fariba Moradi Ardekani; Atefeh Torabi Ardakani; Seyed Mohammad Javad Mortazavi. "Family History of Alzheimer’s Disease Increases the Risk of COVID-19 Positivity: A SUMS Employees Cohort-based Study". سامانه مدیریت نشریات علمی, 13, 4, 1402, 363-366. doi: 10.31661/jbpe.v0i0.2104-1318
Masoumi, Seyed Jalil, Haghani, Masoud, Mokkaram, Pooneh, Firoozi, Donya, Mortazavi, Seyed Ali Reza, Moradi Ardekani, Fariba, Torabi Ardakani, Atefeh, Mortazavi, Seyed Mohammad Javad. (1402). 'Family History of Alzheimer’s Disease Increases the Risk of COVID-19 Positivity: A SUMS Employees Cohort-based Study', سامانه مدیریت نشریات علمی, 13(4), pp. 363-366. doi: 10.31661/jbpe.v0i0.2104-1318
Masoumi, Seyed Jalil, Haghani, Masoud, Mokkaram, Pooneh, Firoozi, Donya, Mortazavi, Seyed Ali Reza, Moradi Ardekani, Fariba, Torabi Ardakani, Atefeh, Mortazavi, Seyed Mohammad Javad. Family History of Alzheimer’s Disease Increases the Risk of COVID-19 Positivity: A SUMS Employees Cohort-based Study. سامانه مدیریت نشریات علمی, 1402; 13(4): 363-366. doi: 10.31661/jbpe.v0i0.2104-1318

Family History of Alzheimer’s Disease Increases the Risk of COVID-19 Positivity: A SUMS Employees Cohort-based Study

Journal of Biomedical Physics and Engineering
مقاله 8، دوره 13، شماره 4، آبان 2023، صفحه 363-366    اصل مقاله (598.49 K)
نوع مقاله: Original Research
شناسه دیجیتال (DOI): 10.31661/jbpe.v0i0.2104-1318
نویسندگان
Seyed Jalil Masoumi1، 2، 3؛ Masoud Haghani4؛ Pooneh Mokkaram5؛ Donya Firoozi6؛ Seyed Ali Reza Mortazavi7؛ Fariba Moradi Ardekani3؛ Atefeh Torabi Ardakani3؛ Seyed Mohammad Javad Mortazavi* 8
1Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Science, Shiraz, Iran
2Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3Center for Cohort Study of SUMS Employees’ Health, Shiraz University of Medical Sciences, Shiraz, Iran
4Department of Radiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
5Department of Biochemistry, Autophagy Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
6Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
7School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
8Department of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Substantial data indicate that genetic and environmental factors play a key role in determining the risk of Alzheimer’s disease (AD). Moreover, it is known that having relatives with AD increases the risk of developing this disease.
Objective: This study is aimed at investigating whether having a family history of AD, may increase the risk of COVID-19 in a cohort-based study.
Material and Methods: Participants of this retrospective cohort study were previously enrolled in the SUMS Employees Cohort (SUMSEC). All participants including those whose SARS-CoV-2 infection was confirmed by positive PCR test and chest CT scan were requested to respond to interviewer-administered questionnaires. Moreover, AD was diagnosed via memory and thinking impairment, concentration problems, confusion with location, and problems in finishing daily tasks.
Results: The total numbers of female and male participants with a family history of AD were 463 and 222 individuals, respectively. When all types of family history of AD were considered, a 51.3% increase was found in the relative frequency of the participants with both family history of AD and confirmed COVID-19 compared with those only with a family history of AD. 
Conclusion: Despite the limitations of our study, and from a broader perspective, our findings can further support the concept that AD risk haplotypes including APOE are linked to the same morbidities from cardiovascular disease and obesity that increase vulnerability to COVID-19. Given this consideration, millions of APOE ε4 carriers around the globe should be advised to take additional precautions to prevent life-threatening diseases such as COVID-19.

تازه های تحقیق

Seyed Jalil Masoumi (Google Scholar)

Seyed Mohammad Javad Mortazavi (Google Scholar)

کلیدواژه‌ها
Alzheimer’s Disease؛ APOe4 Gene؛ SARS-CoV-2؛ COVID-19
سایر فایل های مرتبط با مقاله
مراجع
  1. Strapazzon G, Hilty MP, Bouzat P, et al. To compare the incomparable: COVID-19 pneumonia and high-altitude disease. Eur Respir J. 2020;55(6): 2001362. doi: 10.1183/13993003.01362-2020. PubMed PMID: 32398299. PubMed PMCID: PMC7315003.
  2. Woolf SH, Chapman DA, Lee JH. COVID-19 as the leading cause of death in the United States. JAMA. 2021;325(2):123-4. doi: 10.1001/jama.2020.24865. PubMed PMID: 33331845.
  3. Pak A, Adegboye OA, Adekunle AI, et al. Economic consequences of the COVID-19 outbreak: the need for epidemic preparedness. Front Public Health. 2020;8:241. doi: 10.3389/fpubh.2020.00241. PubMed PMID: 32574307. PubMed PMCID: PMC7273352.
  4. Bird TD. Genetic aspects of Alzheimer disease. Genet Med. 2008;10(4):231-9. doi: 10.1097/GIM.0b013e31816b64dc. PubMed PMID: 18414205. PubMed PMCID: PMC2690397.
  5. Roses AD. On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease. J Alzheimers Dis. 2006;9(s3):361-6. doi: 10.3233/JAD-2006-9S340. PubMed PMID: 16914873.
  6. Kamboh MI. Molecular genetics of late-onset Alzheimer’s disease. Ann Hum Genet. 2004;68(4):381-404. doi: 10.1046/j.1529-8817.2004.00110.x. PubMed PMID: 15225164.
  7. Bertram L, Tanzi RE. The current status of Alzheimer’s disease genetics: what do we tell the patients? Pharmacol Res. 2004;50(4):385-96. doi: 10.1016/j.phrs.2003.11.018. PubMed PMID: 15304236.
  8. Serretti A, Artioli P, Quartesan R, De Ronchi D. Genes involved in Alzheimer’s disease, a survey of possible candidates. J Alzheimers Dis. 2005;7(4):331-53. doi:10.3233/JAD-2005-7410. PubMed PMID: 16131736.
  9. EURODEM Risk Factors Research Group. Interaction between genetic and environmental risk factors for Alzheimer’s disease: A reanalysis of case-control studies. Genet Epidemiol. 1994;11(6):539-51. doi: 10.1002/gepi.1370110609. PubMed PMID: 7713394.
  10. Grant WB, Campbell A, Itzhaki RF, Savory J. The significance of environmental factors in the etiology of Alzheimer’s disease. J Alzheimers Dis. 2002;4(3):179-89. doi: 10.3233/jad-2002-4308. PubMed PMID: 12226537.
  11. Killin LO, Starr JM, Shiue IJ, Russ TC. Environmental risk factors for dementia: a systematic review. BMC Geriatr. 2016;16(1):1-28. doi: 10.1186/s12877-016-0342-y. PubMed PMID: 27729011. PubMed PMCID: PMC5059894.
  12. Bekris LM, Yu CE, Bird TD, Tsuang D. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23(4):213-27. doi: 10.1177/0891988710383571.
  13. Nicolas G, Acuña-Hidalgo R, Keogh MJ, et al. Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer’s disease. Alzheimers Dement. 2018;14(12):1632-9. doi: 10.1016/j.jalz.2018.06.3056. PubMed PMID: 30114415. PubMed PMCID: PMC6544509.
  14. Liljegren M, Landqvist Waldö M, Rydbeck R, Englund E. Police Interactions Among Neuropathologically Confirmed Dementia Patients. Alzheimer Dis Assoc Disord. 2018;32(4):346-50. doi: 10.1097/wad.0000000000000267. PubMed PMID: 30095442.
  15. Tong BC, Wu AJ, Li M, Cheung KH. Calcium signaling in Alzheimer’s disease & therapies. Biochim Biophys Acta Mol Cell Res. 2018;1865(11):1745-60. doi: 10.1016/j.bbamcr.2018.07.018. PubMed PMID: 30059692.
  16. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. 1997;278(16):1349-56. PubMed PMID: 9343467.
  17. Zhao Y, Zhao Z, Wang Y, et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020. doi: 10.1101/2020.01.26.919985.
  18. Kulminski AM, Loika Y, Culminskaya I, et al. Independent associations of TOMM40 and APOE variants with body mass index. Aging Cell. 2019;18(1):e12869. doi: 10.1111/acel.12869. PubMed PMID: 30462377. PubMed PMCID: PMC6351823.
  19. Kulminski AM, Raghavachari N, Arbeev KG, et al. Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study. 2016;17(5):893-905. doi: 10.1007/s10522-016-9659-3. PubMed PMID: 27447179. PubMed PMCID: PMC5065761.
  20. Finch CE, Kulminski AM. The ApoE locus and COVID-19: are we going where we have been? J Gerontol A Biol Sci Med Sci. 2021;76(2):e1-3. doi: 10.1093/gerona/glaa200. PubMed PMID: 32777042. PubMed PMCID: PMC7454416.
  21. Kasparian K, Graykowski D, Cudaback E. Commentary: APOE E4 Predicts Severe COVID-19 in the UK Biobank Community Cohort. Front Immunol. 2020;11:1939. doi: 10.3389/fimmu.2020.01939. PubMed PMID: 33042114. PubMed PMCID: PMC7522160.
آمار
تعداد مشاهده مقاله: 22,427
تعداد دریافت فایل اصل مقاله: 611


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب